Immunocore Holdings plc IMCR
30.99 USD +2.59 (+9.12%)
At closeNov 6, 2026, 4:00 PM EST
30.99 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
29.15 Day range 31.28
27.79 52-week range 40.22
- YTD
- -10.72%
- 1 year
- -1.90%
Analyst view
Consensus: buy
Buy
Price target (mean) 60.80 +96.2% upside
Now 30.99
- Target (low)
- 33.00
- Target (mean)
- 60.80
- Target (high)
- 100.00
Ratings (0m) 12 8 buy · 4 hold · 0 sell
- Strong buy2
- Buy6
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 13
- 2 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.18341 | -0.46 – 0.07 | -0.60 | +69.4% | 116.86M | +11.8% | 11 |
| Next quarter | -0.14 | -0.27 – -0.05 | 0.25 | -156.0% | 122.12M | +14.5% | 5 |
| Current year | -0.0646 | -0.46 – 0.22 | -0.71 | +90.9% | 452.62M | +13.1% | 10 |
| Next year | -0.96301 | -3.80 – 0.13 | -0.09146 | -952.9% | 482.05M | +6.5% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 26, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 3, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Apr 20, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 14, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 16, 2026 | Jefferies | Downgrade | Buy | Hold |
| Feb 26, 2026 | Needham | Maintained | Buy | Buy |
| Feb 4, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 10, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 31, 2025 | Wells Fargo | Initiated | — | Overweight |
| Oct 22, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 2, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 14, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 10, 2025 | Needham | Reiterated | Buy | Buy |
| Apr 7, 2025 | Mizuho | Maintained | Neutral | Neutral |
| Mar 12, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 12, 2025 | Needham | Reiterated | Buy | Buy |
| Mar 5, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 28, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 27, 2025 | Needham | Reiterated | Buy | Buy |
| Jan 27, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 10, 2025 | Needham | Reiterated | Buy | Buy |
| Dec 13, 2024 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Nov 11, 2024 | Mizuho | Downgrade | Outperform | Neutral |
| Nov 7, 2024 | Needham | Maintained | Buy | Buy |
| Oct 24, 2024 | UBS | Initiated | — | Sell |
| Oct 24, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 11, 2024 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 7, 2024 | Guggenheim | Downgrade | Buy | Neutral |
| Sep 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |